Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07631598 · ClinicalTrials.gov registry record · NA
Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
A NA study, sponsored by Montefiore Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 512
- Enrollment target
NCT07631598 is a NA study that has not yet begun recruiting, run by Montefiore Medical Center. The registered enrollment target is 512 participants.
The verdict
NCT07631598, a NA study, has not yet begun recruiting, sponsored by Montefiore Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 512 participants
- Enrollment target
Study Summary
This study is testing whether offering buprenorphine treatment directly at syringe service programs (SSPs) helps more people start and stay in treatment for opioid use disorder (OUD) than referring them to community buprenorphine treatment providers. Buprenorphine is a medication that helps reduce opioid cravings and withdrawal symptoms. The study compares two ways of connecting people to treatment: Referral to a community treatment provider (usual care before the new program begins). Onsite, low-threshold buprenorphine treatment at the SSP, which allows participants to start medication quickly and without having to establish care at another provider. Participants will be adults who have opioid use disorder and are SSP clients. Each SSP will begin offering the new onsite buprenorphine program at different times during the study. Researchers will collect information before and after the new program begins to see how it affects treatment engagement and health outcomes. The study will also examine how easy or difficult it is for SSPs to start and run the new program, how acceptable it is to staff and participants, and whether it is cost-effective. The overall goal is to find better ways to expand access to life-saving opioid treatment in community-based settings.
Interventions
- OTHER Standard of Care Referral
- BEHAVIORAL Low Threshold Buprenorphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 512 participants |
| Start Date | 2026-08-10 |
| Est. Completion | 2028-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07631598
The ClinicalTrials.gov registry entry for NCT07631598 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 512 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care Referral is the first listed.
NCT07631598 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07631598 about?
NCT07631598 is a clinical study titled "Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses". This study is testing whether offering buprenorphine treatment directly at syringe service programs (SSPs) helps more people start and stay in treatment for opioid use disorder (OUD) than referring them to community buprenorphine treatment providers. Buprenorphine is a medication that helps reduce o...
What is the current status of trial NCT07631598?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 512 participants. The study started on 2026-08-10. Estimated completion is 2028-06.
What interventions are being tested in trial NCT07631598?
The interventions under investigation include: Standard of Care Referral (OTHER), Low Threshold Buprenorphine (BEHAVIORAL).
Who is sponsoring clinical trial NCT07631598?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.